Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,625,143
+$553,948 QoQ
Shares Held
18,380
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,364
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Telos Capital Management, Inc. holds $41,593,885 across 9 Drug Manufacturers - General names. ABBV ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,049 | $11,695,064 | |
| 2 | AMGN |
Amgen Inc
|
25,990 | $9,411,498 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
111,780 | $6,440,763 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
18,380 | $4,625,143 | |
| 5 | NVS |
Novartis AG
|
25,483 | $3,993,695 | |
| 6 | LLY |
ELI LILLY & Co
|
2,302 | $2,761,088 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,035 | $1,803,497 | |
| 8 | PFE |
Pfizer Inc
|
25,954 | $624,972 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,625,143 | 18,380 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,071,195 | 18,719 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $4,361,874 | 19,090 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $4,477,983 | 19,340 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,689,383 | 19,876 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,235,027 | 20,213 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,078,392 | 22,951 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,804,885 | 24,331 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $4,283,368 | 24,973 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,630,256 | 25,427 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $7,939,887 | 51,235 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $7,571,949 | 50,798 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $6,722,757 | 49,898 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $8,030,176 | 50,387 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $8,781,725 | 54,339 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $7,266,129 | 54,140 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $8,266,964 | 53,976 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $8,841,317 | 54,539 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,623,561 | 56,304 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $6,231,002 | 57,764 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $8,195,799 | 72,761 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,921,812 | 73,201 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $7,839,951 | 73,168 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $6,752,050 | 77,087 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $7,613,760 | 77,549 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $5,426,175 | 71,219 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||